Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

CNS Drugs

Issue 4/2013

Content (7 Articles)

Leading Article

Switching Therapies in Multiple Sclerosis

Patricia K. Coyle

Open Access Current Opinion

Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis

Giulio Scigliano, Gabriele Ronchetti

Therapy in Practice

Management of Motor and Non-Motor Symptoms in Parkinson’s Disease

Fabienne Sprenger, Werner Poewe

Systematic Review Article

Pharmacotherapy of Focal Epilepsy in Children: A Systematic Review of Approved Agents

Ravindra Arya, Tracy A. Glauser

Review Article

Management of Alcohol Dependence in Patients with Liver Disease

Giovanni Addolorato, Antonio Mirijello, Lorenzo Leggio, Anna Ferrulli, Raffaele Landolfi

Review Article

Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence

Jerome Sarris, Erica McIntyre, David A. Camfield

Original Research Article

Safety and Efficacy of Intravenous Lacosamide for Adjunctive Treatment of Refractory Status Epilepticus: A Comparative Cohort Study

Raoul Sutter, Stephan Marsch, Stephan Rüegg

Mar 13
Issue: 3/2013
May 13
Issue: Special Issue 1/2013
Optimizing Outcomes in Major Depressive Disorder via Augmentation Therapy - Focus on the Role of Atypical Antipsychotics

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more